Voyager Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $148.3M | $224.2M | $131.9M |
| Jun 2022 | $128.6M | $188.6M | $78.3M |
| Sep 2022 | $102.7M | $182.5M | $96.9M |
| Dec 2022 | $100.3M | $159.4M | $99.0M |
| Mar 2023 | $119.3M | $336.3M | $268.3M |
| Jun 2023 | $116.5M | $315.5M | $244.3M |
| Sep 2023 | $118.4M | $294.7M | $65.3M |
| Dec 2023 | $115.0M | $351.3M | $68.8M |
| Mar 2024 | $128.7M | $469.6M | $143.1M |
| Jun 2024 | $100.8M | $436.2M | $76.1M |
| Sep 2024 | $95.7M | $426.0M | $112.5M |
| Dec 2024 | $93.3M | $393.1M | $71.4M |
| Mar 2025 | $80.5M | $353.2M | $74.8M |
| Jun 2025 | $78.2M | $322.1M | $43.9M |
| Sep 2025 | $68.5M | $288.3M | $45.1M |
| Dec 2025 | $56.2M | $252.3M | $65.3M |
| Mar 2026 | $45.7M | $219.3M | $43.3M |
| Jun 2026 | $43.4M | $197.8M | $35.8M |